FOLH1 and prostate carcinoma: Thus, its expression at the apical surface suggests exposure to poly-gamma-glutamated folate and likely also free folate at this surface, possibly from dead or dying prostate carcinoma cells that release their content, including their stored poly-gamma glutamate folates in their surrounding environment where they become available to PSMA overexpressed on viable cancer cells.